SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FIIs hike shareholding in Lupin to 28.8% in March 2013 quarter

12 Apr 2013 Evaluate

Foreign institutional investors (FIIs) have hiked their shareholding in pharma major, Lupin, to historic highs of 28.8% in March 2013 quarter from 27.76% at the end of December 2012 quarter. FIIs bought 4.66 million shares worth of Rs 279 crore in January-March quarter.

Lupin is the 5th largest and fastest growing generics player in the US (5.1% market share by prescriptions, IMS Health) and the 3rd largest Indian pharmaceutical company by sales. The company is also the fastest growing top 10 generic pharmaceutical players in Japan and South Africa (IMS).

Lupin Share Price

2369.45 -26.55 (-1.11%)
24-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1941.00
Dr. Reddys Labs. 1152.60
Cipla 1410.90
Lupin 2369.45
Zydus Lifesciences 1108.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: